Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03544112 · ClinicalTrials.gov registry record
Emergency Department Connection to Care With Buprenorphine for Opioid Use Disorder
A clinical trial, sponsored by NYU Langone Health.
- Completed
- Registry status
- 390
- Enrollment target
NCT03544112: Completed study, sponsored by NYU Langone Health.
NCT03544112 is a clinical trial that has completed, run by NYU Langone Health. The registered enrollment target is 390 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03544112 has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- 390 participants
- Enrollment target
Study Summary
The purpose of this study is to learn what resources are needed to improve outcomes for patients with opioid use disorder. The study will look at how patients engage in treatment and the decisions that patients and providers make regarding treatment, specifically buprenorphine treatment, for opioid use disorder. The aims of this study are: 1. To evaluate using mixed methods the feasibility and acceptability of OUD screening, ED-initiated BUP, and referral. 2. Over the course of the study and as XR-BUP is added to hospital formularies, to estimate the percentage and confidence intervals of patients assessed, treated, and engaged in treatment at Day 30. This will be a three-site study employing a multi-faceted approach to facilitate clinical protocol implementation and to assess feasibility, acceptability, and impact. Investigators will develop, introduce and update site-specific ED clinical protocols and implementation plans for OUD screening, ED-initiated BUP, and referral for treatment. A participatory action research approach will be utilized along with mixed methods incorporating data derived from: * Medical record and administrative data abstraction, * Research assessments involving patients who are eligible for and willing to receive ED-initiated BUP (including both those who do, and do not, receive BUP); these assessments will document the index ED visit and the 30th day after the index ED visit, * Qualitative interviews, focus groups, and quantitative assessments involving providers and staff, patients, and other stakeholders.
Primary Outcome
Proportion receiving emergency department BUP amongst patients who have been determined to be eligible for and willing to receive ED-initiated BUP
Interventions
- BEHAVIORAL Employ a multifaceted approach to facilitate clinical protocol implementation
- DRUG Initiate BUP (SL-BUP or XR-BUP) in the ED
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 390 participants |
| Start Date | 2018-06-11 |
| Est. Completion | 2019-05-29 |
What the finished NCT03544112 record still lists
NCT03544112 is an observational study that tracks outcomes without assigning an intervention. The registered 390 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Employ a multifaceted approach to facilitate clinical protocol implementation is the first listed.
NCT03544112 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03544112 about?
NCT03544112 is a clinical study titled "Emergency Department Connection to Care With Buprenorphine for Opioid Use Disorder". The purpose of this study is to learn what resources are needed to improve outcomes for patients with opioid use disorder. The study will look at how patients engage in treatment and the decisions that patients and providers make regarding treatment, specifically buprenorphine treatment, for opioid ...
What is the current status of trial NCT03544112?
This trial is currently completed. The enrollment target is 390 participants. The study started on 2018-06-11. Estimated completion is 2019-05-29.
What interventions are being tested in trial NCT03544112?
The interventions under investigation include: Employ a multifaceted approach to facilitate clinical protocol implementation (BEHAVIORAL), Initiate BUP (SL-BUP or XR-BUP) in the ED (DRUG).
Who is sponsoring clinical trial NCT03544112?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00397111 · 390 participants
Development of Magnetic Resonance Imaging Techniques for Studying Mood and Anxiety Disorders
- NCT05335928 · 390 participants · Phase 3
Abatacept in Immune Checkpoint Inhibitor Myocarditis
- NCT05445960 · 390 participants · NA
Correlation Between Intraoperative Tourniquet Use and Limb pH, Functional Measures and Patient-reported Outcomes After Ankle Fracture Surgery
- NCT05997615 · 390 participants · Phase 1
Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI